Details for New Drug Application (NDA): 018631
✉ Email this page to a colleague
The generic ingredient in TRENTAL is pentoxifylline. There are fourteen drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the pentoxifylline profile page.
Summary for 018631
Tradename: | TRENTAL |
Applicant: | Validus Pharms |
Ingredient: | pentoxifylline |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 018631
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
Approval Date: | Aug 30, 1984 | TE: | RLD: | Yes |
Expired US Patents for NDA 018631
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Validus Pharms | TRENTAL | pentoxifylline | TABLET, EXTENDED RELEASE;ORAL | 018631-001 | Aug 30, 1984 | ⤷ Sign Up | ⤷ Sign Up |
Validus Pharms | TRENTAL | pentoxifylline | TABLET, EXTENDED RELEASE;ORAL | 018631-001 | Aug 30, 1984 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription